Platelet-rich plasma
Autologous PRP options are considered for appropriate wounds as part of a documented wound-bed and tissue-repair strategy.
Advanced Wound Care Procedures
Advanced treatment starts with the fundamentals.
Advanced wound care at CWS brings PRP, regenerative peptides (BPC-157 and TB-500), UltraMIST non-contact ultrasound, and adipose-derived biologics that turn a patient's own fat into regenerative material into the same practice that manages virtual evaluation, clinic procedures, tele-wound follow-up, and surgical intervention when appropriate.
Treatment menu
Advanced treatment is not a handoff. It is part of the plan.
For wounds that are complex from the start or have stalled, advanced treatment is selected inside the same evaluation-first pathway. CWS evaluates the wound, chooses the appropriate treatment layer, and keeps the same clinical team responsible through closure.
Regenerative peptides
Physician-directed peptide therapy, including BPC-157 and TB-500, is reviewed case by case to support tissue repair, with eligibility, sourcing, safety, and compliance handled before any treatment decision.
UltraMIST® ultrasound
Non-contact low-frequency ultrasound therapy (UltraMIST) supports wound-bed preparation, biofilm disruption, and the timing of biologic or procedural escalation.
Turning fat into biologics
Adipose-derived biologics turn a patient’s own fat into regenerative material, selected alongside skin substitutes around wound type, vascular supply, infection status, and documentation requirements.
Insurance note
Some advanced wound-care procedures may be covered by Medicare, Medicaid, or commercial plans when medical-necessity and documentation criteria are met. Coverage varies by diagnosis, product, plan, and prior authorization requirements. Inquire before scheduling so the team can review eligibility.
Advanced wound care
Technology that changes the decision.
Fluorescence imaging
Identify clinically significant bacterial burden.
Molecular diagnostics
Help identify organisms when clinically appropriate.
Ultrasonic wound technology
Advanced assessment and treatment capabilities.
Advanced debridement
Removal of non-viable tissue to restart healing, at the bedside or in the surgical suite.
Virtual wound evaluation
Specialist review of history, images and the wound itself, often within days.
Surgical intervention
Escalation to our ambulatory surgical center when the wound needs it.
RegenWound Protocol
A coordinated pathway for wounds that need more than dressings.
The RegenWound Protocol is the CWS care sequence for wounds that need more than dressings: evaluation, wound-bed preparation, regenerative treatment selection, tele-wound follow-up, and surgical intervention when appropriate.
-
Step 01
Confirm the wound is ready.
Assess perfusion, infection risk, depth, drainage, prior therapies, and the reason the wound has stalled.
- Wound staging
- Vascular review
- Infection screen
-
Step 02
Choose the regenerative layer.
Select PRP, regenerative peptides (BPC-157, TB-500), UltraMIST ultrasound, or adipose-derived biologics when clinically appropriate.
- PRP
- Adjunct review
- Advanced biologics
-
Step 03
Keep the patient inside CWS.
Tele-wound check-ins, clinic procedures, and surgical escalation remain connected to the same team, with notes back to the existing care team at every step.
- Tele-wound follow-up
- Clinic escalation
- Same-team continuity
Limb preservation, by design
The goal is not just healing. It is keeping the limb.
Advanced wound-care procedures are positioned inside the larger limb-preservation continuum: treat infection earlier, reduce avoidable amputation risk, and escalate before a salvageable limb is lost.
Outcome 01
Lower amputation risk.
Regenerative care is paired with debridement, biologics, structural correction, and OR access when a limb is still salvageable.
Outcome 02
Reduced infection progression.
Earlier escalation, coordinated follow-up, and surgical access help prevent wounds from drifting into emergency infection pathways.
Outcome 03
One provider. That’s it.
The same clinical team owns the case from first assessment through advanced treatment, surgical escalation, and closure.
Diagnostic evaluation
Advanced molecular testing for complex and non-healing wounds.
A wound that stops healing may be telling us something. Infection, microbial burden, vascular disease, pressure, edema, tissue necrosis, metabolic factors, and other barriers can all contribute to delayed healing.
When clinically appropriate, CWS can incorporate advanced molecular laboratory testing, including PCR-based testing, as part of a comprehensive evaluation of a stalled or complex wound.
Molecular testing can identify microbial DNA and selected resistance markers included in the laboratory panel. Results are considered alongside symptoms, wound appearance, healing trajectory, medical history, vascular status, previous treatments, medications, and other diagnostic information.
Technology provides information. Physicians determine what it means.
About molecular wound testing →Advanced Wound Care · RegenWound · Coverage Review
Ask whether your wound patient is a fit for RegenWound.
Request an evaluation. The care team will explain how to share relevant clinical records securely and review whether an advanced wound-care pathway makes sense.